Review Article

Advances in Cell Transplantation Therapy for Diseased Myocardium

Table 2

Cell types and delivery methods in cardiac functional outcome.

Cell injection to myocardium
ModelCell type×106 cellsFunctionRemarks

MouseBMSC0.0175–0.1Regeneration[1]
RatBMSC10Arrhythmogenicity[24]
RatBMSC20[23]
RatCM0.2Regeneration[6]
RatCM5Cell washout[16]
RatMyoblast1Improved exercise capacity[28]
RatMyoblast2.3[29]
RatMyoblast10Arrhythmogenicity[23]
RabbitFB↑ diastolic, systolic performance[30]
RabbitMyoblast[30]
SheepMyoblast[31]
SwineBMSC100Cell washout[17]
SwineBMSC100High cell homing[25]

Vascular infusion
ModelCell type×106 cellsFunctionRemarks  

MouseBMSC20Regeneration[3]
RatBMSC10[24]
SwineBMSC100Cell washout[25]

Cell sheets
ModelCell typeNr of sheetsFunctionRemarks  

HamsterMyoblast2 layersHigher life expectancy[32]
RatAdMSCMonolayerParacrine pathways—angiogenesis[33]
RatAdMSCMonolayer[34]
RatCM, SCMonolayerCell survival, proliferation, differentiation[35]
RatCM, EC“Monolayer”Higher vessel density[36]
RatCM2 monolayersIntegration of graft and myocardium[37]
RatCMBilayer  Functional integration[26]
RatCM3 monolayersIntegration of graft and myocardium[38]
RatCM3 monolayersThick grafts, multiple surgeries[39]
RatFB, EC3 monolayersLess fibrosis[40]
RatMyoblast1–5 monolayersDose-response[41]
RatMyoblast2 monolayersLess fibrosis, remodeling[27]
RatMyoblast2 layersLess fibrosis, higher vessel density[42]
RatMyoblast2 × 5 layersHigher vessel density[43]
RatMyoblast2 × 5 layersParacrine pathways— angiogenesis[44]
SwineMyoblast2–10 layers[45]

AdMSC: adipose tissue-derived mesenchymal stem cell, BMSC: bone marrow stem cell, CM: cardiomyocyte, EC: endothelial cell, FB: fibroblast, SC: stromal cell.